BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12944991)

  • 1. Concurrent induction of T-cell activation and apoptosis of osteosarcoma cells by adenovirus-mediated B7-1/Fas chimeric gene transfer.
    Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yagita H; Okumura K; Yamashita T; Uede T
    Cancer Gene Ther; 2003 Sep; 10(9):717-25. PubMed ID: 12944991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma.
    Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T
    Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes.
    Scholz C; Stärck L; Willimsky G; Blankenstein T; Dörken B; Daniel PT
    Gene Ther; 2002 Nov; 9(21):1438-46. PubMed ID: 12378406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
    Lang S; Atarashi Y; Nishioka Y; Stanson J; Meidenbauer N; Whiteside TL
    Cell Immunol; 2000 May; 201(2):132-43. PubMed ID: 10831322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
    Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
    Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
    Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells.
    Gilligan MG; Knox P; Weedon S; Barton R; Kerr DJ; Searle P; Young LS
    Gene Ther; 1998 Jul; 5(7):965-74. PubMed ID: 9813668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
    Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
    Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
    Hull GW; Mccurdy MA; Nasu Y; Bangma CH; Yang G; Shimura S; Lee HM; Wang J; Albani J; Ebara S; Sato T; Timme TL; Thompson TC
    Clin Cancer Res; 2000 Oct; 6(10):4101-9. PubMed ID: 11051263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo immunogenicity of osteosarcoma cells that express B7-1a, an alternatively spliced form of B7-1.
    Nagamori M; Kawaguchi S; Murakami M; Wada T; Inobe M; Ishii S; Uede T
    Anticancer Res; 2002; 22(4):2009-13. PubMed ID: 12174878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immunological antitumor effects by adenovirus-mediated gene transfer of B7-1 in a murine squamous cell carcinoma cell line.
    Hoshitani Y; Ishida H; Otsuki N; Shirakawa T; Gotoh A; Nibu K
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):270-5. PubMed ID: 17372085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells.
    Nagamori M; Kawaguchi S; Murakami M; Wada T; Nagoya S; Yamashita T; Inobe M; Uede T
    Anticancer Res; 2002; 22(6A):3223-7. PubMed ID: 12530068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy.
    Lohr F; Hu K; Haroon Z; Samulski TV; Huang Q; Beaty J; Dewhirst MW; Li CY
    Mol Ther; 2000 Sep; 2(3):195-203. PubMed ID: 10985949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.
    McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P
    Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
    Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
    Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.